Skip to main content

Table 1 Sociodemographic, clinical, cognitive and neurophysiological values in patients and healthy controls

From: Cognitive outcome and gamma noise power unrelated to neuregulin 1 and 3 variation in schizophrenia

 

All patients (N = 31)

Healthy controls (N = 23)

Age

36.42 (12.07)

31.91 (13.14)

Sex (M:F)

18:13

13:10

Marital status (% singles)**

96.30

68.18

Employment status (% employed)*

42.31

77.27

Education (completed courses)

10.94 (3.81)

11.50 (3.00)

Total IQ**

81.68 (14.20)

104.00 (13.09)

PANSS positive

20.25 (4.33)

N/A

PANSS negative

19.68 (5.54)

N/A

PANSS total

75.46 (12.11)

N/A

BACS - verbal memory***

36.18 (12.38)

54.87 (7.68)

BACS - working memory***

16.93 (5.16)

22.17 (3.77)

BACS - motor speed***

50.24 (15.52)

64.61 (14.85)

BACS - verbal fluency***

16.41 (4.76)

25.48 (4.84)

BACS - processing speed***

37.32 (14.72)

58.57 (12.24)

BACS - problem solving***

12.33 (6.12)

17.52 (3.10)

P3b valid segments (n)

44.87(21.05)

57.13(24.48)

Pz amplitude S2 (P3a; μV)

0.870 (1.125)

1.297 (0.981)

Pz amplitude S3 (P3b; μV)**

0.815 (1.587)

1.935 (0.910)

Gamma noise power F3 (μV2)

0.012 (0.012)

0.009 (0.015)

Gamma noise power F4 (μV2)

0.012 (0.013)

0.008 (0.009)

Gamma noise power P3 (μV2)**

0.012 (0.009)

0.006 (0.004)

Gamma noise power P4 (μV2)**

0.012 (0.007)

0.007 (0.004)

  1. Data specified as percentage (%), simple distribution or pertaining to Mean (S.D.); *p < 0.05; **p < 0.01; ***p < 0.001 (Chi square test or Student's t test when corresponding); N/A, not applicable.